Built using previous funding from the National Institute on Drug Abuse (NIDA), Pro-Change’s Connect2BWell program will undergo additional development and be tested in a nine-month randomized clinical trial. Connect2BWell includes a variety of digital intervention components for both patients and providers.
Patients at-risk receive a brief assessment and intervention based upon the Transtheoretical Model of Behavior Change to determine readiness to quit their most problematic drug and readiness to seek treatment. Patients also receive tailored text messages and access to customized online activities.
Through an integration with the federally qualified health center’s electronic health record, the intervention delivers a provider facing Clinical Dashboard that summarizes the patient’s substance use risk scores and stage of change data, and provides stage-matched scripts and action steps to guide a brief in-person intervention session.
“Pro-Change is thrilled to be able to continue our long history of innovative program development to address unmet needs in substance use treatment.”– Dr. Kerry Evers, Pro-Change Co-President & CEO.
This research is supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R44DA044840. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
In Other News…
You can find us in Mediaplanet’s Future of Work campaign! This campaign aims to bring attention to those organizations and individuals helping provide resources and advice to business owners and workers to help them succeed. View Dr. Sara Johnson & Karen Moseley of HERO’s article on Why A Remote Workplace Needs Strong Social Connections.